BRIEF published on 04/10/2025 at 19:05, 5 days 10 hours ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
BRIEF published on 04/10/2025 at 19:05, 5 days 10 hours ago TME Pharma renforce son contrat de liquidité avec Invest Securities Contrat De Liquidité INVEST SECURITIES Marchés Financiers Oncologie TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 5 days 10 hours ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
PRESS RELEASE published on 04/10/2025 at 19:00, 5 days 10 hours ago Informations privilégiées / Autres communiqués TME Pharma augmente les ressources allouées au contrat de liquidité confié à Invest Securities pour renforcer la trésorerie. Détails des ressources disponibles après l'augmentation Contrat De Liquidité INVEST SECURITIES Trésorerie Ressources TME Pharma
BRIEF published on 02/17/2025 at 08:05, 1 month 26 days ago TME Pharma présente sa feuille de route stratégique et ses initiatives pour 2025 Biotechnologie Partenariats Stratégiques Thérapie Contre Le Cancer Découverte De Médicaments NOX-A12
BRIEF published on 02/17/2025 at 08:05, 1 month 26 days ago TME Pharma Outlines 2025 Strategic Roadmap and Initiatives Strategic Partnerships Biotechnology Drug Discovery Cancer Therapy NOX-A12
PRESS RELEASE published on 02/17/2025 at 08:00, 1 month 26 days ago Inside Information / Other news releases TME Pharma CEO Aram Mangasarian outlines key initiatives and milestones for 2025, including strategic partnerships, NOX-A12 clinical development, AI-driven drug discovery, and financial updates Strategic Partnerships Clinical Development CEO Message TME Pharma 2025 Initiatives
BRIEF published on 01/29/2025 at 08:05, 2 months 17 days ago TME Pharma et aimed analytics : Partenariat innovant pour la découverte de médicaments par l'IA Biotechnologie Partenariat Intelligence Artificielle Cancer Médicaments
BRIEF published on 01/29/2025 at 08:05, 2 months 17 days ago TME Pharma and aimed analytics: Innovative partnership for drug discovery through AI Biotechnology Artificial Intelligence Partnership Cancer Drugs
PRESS RELEASE published on 01/29/2025 at 08:00, 2 months 17 days ago Informations privilégiées / Autres communiqués TME Pharma annonce une collaboration avec aimed analytics pour optimiser la découverte de médicaments par IA, renforçant son profil stratégique Collaboration IA Médicaments TME Pharma Aimed Analytics
Published on 04/16/2025 at 02:25, 2 hours 47 minutes ago New High-Grade Assays Extend Tolmer Silver & Gold Zones
Published on 04/15/2025 at 23:40, 5 hours 32 minutes ago Electric Metals Announces Business Consulting Services Agreement With Terrella Capital
Published on 04/15/2025 at 23:30, 5 hours 42 minutes ago GameSquare Holdings Reports 2024 Full Year Results
Published on 04/15/2025 at 23:30, 5 hours 42 minutes ago AIML Announces Closing of Oversubscribed Private Placement
Published on 04/15/2025 at 23:00, 6 hours 12 minutes ago Cerrado Gold Announces Q1 2025 Production Results At Its Minera Don Nicolas Mine In Argentina
Published on 04/15/2025 at 23:54, 5 hours 18 minutes ago EQS-Adhoc: DATAGROUP enters into an Investment Agreement with and supports a public purchase offer of KKR at a price of EUR 54.00 per share in cash
Published on 04/15/2025 at 21:51, 7 hours 20 minutes ago EQS-Adhoc: Adtran Networks SE updates preliminary results for the financial year 2024
Published on 04/15/2025 at 18:53, 10 hours 19 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/15/2025 at 18:30, 10 hours 42 minutes ago GURIT REPORTS NET SALES OF CHF 85.2 MILLION IN THE FIRST QUARTER OF 2025; ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago ALTHEORA: RESILIENCE DES RESULTATS ANNUELS 2024
Published on 04/15/2025 at 19:00, 10 hours 12 minutes ago Covivio Hotels - Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte des actionnaires du 15 avril 2025
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago NFL Biosciences annonce la mise à disposition de son rapport financier annuel 2024
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago Covivio Hotels - Revenus à fin mars 2025 : la croissance se poursuit
Published on 04/15/2025 at 18:00, 11 hours 12 minutes ago Covivio Hotels - Revenues at end-March 2025: continued growth
Published on 04/15/2025 at 17:45, 11 hours 27 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mars 2025
